Details for New Drug Application (NDA): 020103
✉ Email this page to a colleague
The generic ingredient in ZOFRAN is ondansetron. There are twenty-eight drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the ondansetron profile page.
Summary for 020103
Tradename: | ZOFRAN |
Applicant: | Sandoz |
Ingredient: | ondansetron hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 31, 1992 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 31, 1992 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 24MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Aug 27, 1999 | TE: | RLD: | Yes |
Expired US Patents for NDA 020103
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | ZOFRAN | ondansetron hydrochloride | TABLET;ORAL | 020103-003 | Aug 27, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | ZOFRAN | ondansetron hydrochloride | TABLET;ORAL | 020103-001 | Dec 31, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Sandoz | ZOFRAN | ondansetron hydrochloride | TABLET;ORAL | 020103-001 | Dec 31, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription